Coya Therapeutics, Inc 10-K for FY2025
Coya Therapeutics, Inc. (COYA)
10-K
2026-03-16
For: 2025-12-31
View Original
Added on
April 11, 2026
About this 10-K
Coya Therapeutics, Inc filed this 10-K on March 16, 2026, covering the fiscal year ended December 31, 2025 (FY2025).
Headline figures
Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $7.95M
- up 123.6% from $3.55M a year earlier
- Net loss
- $21.23M
- compared with a net loss of $14.88M a year earlier
- Diluted EPS
- -$1.27
- compared with -$0.98 a year earlier